
|Articles|May 1, 2003
Topical Diclofenac Clears AK Lesions
San Francisco - Diclofenac sodium 3 percent in hyaluronan 2.5 percent gel (Solaraze Gel) offers a useful alternative for topical treatment of actinic keratoses (AKs) in patients with multiple lesions, John E. Wolf Jr., M.D., said at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
4
Phase 2 Nemolizumab Trial Opens for CPUO
5


















